Compare Agilent Technologies Inc (A) vs RLX Technology Inc (RLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs RLX Technology Inc — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while RLX Technology Inc trades at $1.98 (market cap $2.44B). The key difference: Agilent Technologies Inc is far larger — about 17.2× RLX Technology Inc's market cap, and RLX Technology Inc pays the higher dividend (5%). Which is the better fit depends on your goals.
| A | RLX | |
|---|---|---|
Market Cap | $42.00B | $2.44B |
Sector | Health | Technology |
52-Week High | $157.20 | $2.73 |
52-Week Low | $110.24 | $1.79 |
Enterprise Value | $43.55B | $1.07B |
Dividend Yield | 0.69% | 5% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
RLX Technology trades at $2.01, up 1.01% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported Q1 2026 revenue growth to $4.4B with a net profit margin of 22.47%, though it missed EPS estimates for three consecutive quarters. Recent news highlights international expansion, including European integration and a 70% international revenue share.
Outlook is mixed: strong fundamentals with cash flow from operations and no debt support growth, but earnings misses and regulatory risks in the vaping industry pose challenges. The sole analyst coverage recommends Hold, reflecting cautious optimism amid execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About RLX Technology Inc
RLX Technology Inc. is a leading e-vapor company in China, focusing on the research, development, and sale of e-vapor products. The company primarily operates under the RELX brand, offering a range of closed-system e-vapor products designed to deliver a high-quality user experience. RLX's business model is centered on product innovation, strong brand building, and a vast distribution network across China.
Read more on RLX →
